Left ventricular dyssynchrony assessment by phase analysis from gated myocardial perfusion SPECT: Moving beyond conventional criteria

Heart

Volumn 97, Issue 1, 2011, Pages 4-5

  Schindler, Thomas Hellmut ^a   Quercioli, Alessandra ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; EDITORIAL; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE ASYNERGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE PERFUSION; HUMAN; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; GATED BLOOD-POOL IMAGING; HEART FAILURE; HUMANS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 78651256143     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.212167     Document Type: Editorial

References (16)

1. Pazhenkottil AP, Buechel RR, Husmann L, et al. Long-term prognostic value of left ventricular dyssynchrony assessment by phase analysis from myocardial perfusion imaging. Heart 2011;97:33-7.
2. Chen J, Boogers MM, Bax JJ, et al. The use of nuclear imaging for cardiac resynchronization therapy. Curr Cardiol Rep 2010;12:185-91.
3. Chung R, Sutton R, Henein MY. Beyond dyssynchrony in cardiac resynchronisation therapy. Heart 2008;94:991-4. (Pubitemid 352039879)
4. Cho GY, Kim HK, Kim YJ, et al. Electrical and mechanical dyssynchrony for prediction of cardiac events in patients with systolic heart failure. Heart 2010;96:1029-32.
5. Van de Veire NR, Delgado V, Schuijf JD, et al. The role of non-invasive imaging in patient selection. Europace 2009;11(Suppl 5):v32-9.
6. Aljaroudi W, Aggarwal H, Venkataraman R, et al. Impact of left ventricular dyssynchrony by phase analysis on cardiovascular outcomes in patients with end-stage renal disease. J Nucl Cardiol Published Online First: 2010. doi:10.1007/s12350-010-9271-x.
7. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
8. Bax JJ, Van der Wall EE, Schalij MJ. Cardiac resynchronization therapy for heart failure. N Engl J Med 2002;347:1803-4.
9. Mollema SA, Bleeker GB, van der Wall EE, et al. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure. Am J Cardiol 2007;100:1665-70.
10. van Bommel RJ, Gorcsan J3rd, Chung ES, et al. Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT. Heart 2010;96:1107-13.
11. Yu CM, Chan YS, Zhang Q, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 2006;48:2251-7.
12. Van de Veire NR, Bleeker GB, De Sutter J, et al. Tissue synchronisation imaging accurately measures left ventricular dyssynchrony and predicts response to cardiac resynchronisation therapy. Heart 2007;93:1034-9.
13. Yu CM, Bax JJ, Monaghan M, et al. Echocardiographic evaluation of cardiac dyssynchrony for predicting a favourable response to cardiac resynchronisation therapy. Heart 2004;90(Suppl 6):vi17-22.
14. Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008;117:2608-16.
15. Trimble MA, Velazquez EJ, Adams GL, et al. Repeatability and reproducibility of phase analysis of gated single-photon emission computed tomography myocardial perfusion imaging used to quantify cardiac dyssynchrony. Nucl Med Commun 2008;29:374-81.
16. Henneman MM, Chen J, Dibbets-Schneider P, et al. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT? J Nucl Med 2007;48:1104-11.